Julio del Río-Garma

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

Javier de la Rubia, Federico Moscardó, María Gómez et al. · Transfusion and Apheresis Science · 2010 · 59 citations

Thrombosis, Venous Thrombosis, Adult Patients +5

Methylene blue‐photoinactivated plasma <i>versus</i> quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study

Julio del Río-Garma, Alberto Álvarez‐Larrán, Clara Martínez et al. · British Journal of Haematology · 2008 · 57 citations · Full text

Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura

Cristina Pascual, María Eva Mingot‐Castellano, A Fuentes et al. · Blood Advances · 2022 · 49 citations · Full text

Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

Cristina Pascual, Julio del Río-Garma, Javier de la Rubia et al. · Journal of Clinical Apheresis · 2021 · 21 citations

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)

Paul Coppo, Michaël Bubenheim, Y. Benhamou et al. · EClinicalMedicine · 2025 · 21 citations · Full text